CN1650893A - Health care product for treating intestine duct disease, preparation and use method thereof - Google Patents
Health care product for treating intestine duct disease, preparation and use method thereof Download PDFInfo
- Publication number
- CN1650893A CN1650893A CNA2004100603132A CN200410060313A CN1650893A CN 1650893 A CN1650893 A CN 1650893A CN A2004100603132 A CNA2004100603132 A CN A2004100603132A CN 200410060313 A CN200410060313 A CN 200410060313A CN 1650893 A CN1650893 A CN 1650893A
- Authority
- CN
- China
- Prior art keywords
- viable bacteria
- goods
- health
- intestinal tract
- preventing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
A health-care food for preventing and treating intestinal diseases, diabetes, hyperlipemia, obesity, etc is composed of the living bacterium food A prepared from useful bacteria and konjak starch and the living bacterium food B prepared from oligoisomaltose and pectine.
Description
Technical field
The invention belongs to the health-care products technical field, relate to a kind of health-care products and preparation using method thereof of preventing and treating intestinal tract disease.
Background technology:
In recent years, raising along with people's living standard, because people's food configuration and dietary habit change, the thing of taking food subtilized, lack cellulose in the body, cause that the little ecology of enteral is day by day unbalance, cause constipation, diarrhoea, intestinal tract disease large tracts of land such as concurrent intestinal cancer take place, and intestinal tract disease has become a key factor of harm humans health.
The method of conventional control intestinal tract disease mainly contains: the one, and directly edible multifilament food increases body inner cellulose content, prevents this disease to take place; The 2nd, take oral purgative or antibiotics, treat this disease.Preceding kind method must change the many people of people's eating patterns and be reluctant to accept; The latter is to control, and it is slow to take effect, and exists and cures the symptoms, not the disease, and is difficult to defectives such as elimination.
Summary of the invention:
The inventor is at present people's dietary habit, eating patterns change present situation and trend, observe intestinal tract disease incidences such as obstipation, diarrhoea and concurrent intestinal cancer, analyze the problem that exists in the existing Prevention Technique method, purpose is to study and a kind ofly can adapts to people's dietary habit, do not change the thing of taking food, can prevent and treat the health-care products and the preparation using method thereof of intestinal tract disease again preferably.
The technical solution used in the present invention is, the one, adopt the health-care products of forming by viable bacteria goods and viable bacteria food article of preventing and treating intestinal tract disease, and wherein the viable bacteria goods comprise following weight portion raw material: probiotic bacteria 6-15, Rhizoma amorphophalli powder 4-9; Wherein the viable bacteria food article comprises following weight portion raw material: oligomeric isomaltose 30-60, pectin 10-40, alginate jelly 10-40, Rhizoma amorphophalli powder 10-40; Two provide a kind of preparation using method of described health-care products, being about to described viable bacteria goods places in the integument, press 1-3 and 5-10 part by weight collocation suit with described viable bacteria food article, be prepared into combination dosage forms and prevent and treat the health-care products of intestinal tract disease, the common cooperation pressed the consumption use, thereby constitutes a kind of health-care products and preparation using method thereof of preventing and treating intestinal tract disease of the present invention.The inventor calls " 1+1 " counterbalanced procedure to this scheme.
In such scheme, described viable bacteria goods, be used for by oral directly to the human body probiotic supplemented, because host's dietary habit, change such as eating patterns and age, probiotics is at space-time in the body, kind and quantitatively can thereupon have corresponding dynamic to change, cause some physiological and biochemical index of host also to change a lot, as constipation, diarrhoea, the concurrent intestinal cancer of meeting of a specified duration, anusitis etc., probiotic supplemented in body, keep or increase the normal quantity of probiotics, can strengthen operational efficiency with harmful bacterium, and engulf and decompose noxious substance, improve microecological environment in the intestinal, play the effect of directly edible multifilament food that substitute to human body supplementary fibre element and Drug therapy; Described viable bacteria food article, be mainly used in to the enteral viable bacteria food nutrition is provided, and impel probiotic bacteria to multiply propagation in a large number at enteral, improve survival rate and field planting rate, excite the activity of enteral probiotics, improve its combat capabilities, also play control because of the subtilized diabetes that cause of eating patterns, hyperlipidemia, hyperglycemia, hypofunction of liver and cholesterol reducing, antiobesity action: the preparation of described combination dosage forms goods and using method, not only play both to human body enteral probiotic supplemented, promote probiotic bacteria propagation, excite the probiotics activity, the effect of two-ways regulation enteral microecological balance, slow down the infringement of gastric acid but also can alleviate, reach purpose and effect that the present invention had had not only prevented and treated intestinal tract disease but also disease-prevention health preferably viable bacteria.
In the raw material and preparation of the described health-care products of technical scheme, described probiotic bacteria is at least a probiotic bacteria, can be bifidus bacillus (Bifidobacterium), lactobacillus (Lactobacillus), bacillus cereus (Bacillus) or other probiotic bacteria as human body, as bifidus bacillus healthy most important to the host, its main place occupy ileum and colon, follow the host lifelong, nontoxic, other flora played develop the good and eliminate the bad, the effect of upholding the good and suppress the bad, affect people's physiological change and immunologic function, it has or not or number is to weigh one of health sign.As lactobacillus, can regulate the body gastrointestinal tract dysbacteriosis, keep the intestinal microecology balance, can stop the pathogen invasion, to the nutritious effect of intestinal, be beneficial to the reparation of gut barrier, its metabolite can promote gastrointestinal motility, can significantly reduce the absorption of intestinal to cholesterol, can obviously activate phagocytosis, be equivalent to Active immunity, can decompose protein in the food, saccharide synthetic vitamin, fat is had certain capacity of decomposition, improve food digestion rate and biological value, the energy blood fat reducing, decompose carcinogenic substances reduces the generation of disease.Described Rhizoma amorphophalli powder, the gastric emptying speed that can slow down is postponed chyme and is entered duodenal process, delay digesting and assimilating of sugared nutrient substance, increase chyme and form big glue, thereby the erstricted diet nutritional labeling contacts with digestive enzyme and dilutes digestive enzyme and make its active reduction, and digestion process slows down, and enzymatic activity relevant with the sugar decomposition metabolism in the liver is raise, the Insulin receptor INSR number increases the insulin affinity on the hepatocyte, also plays the binding agent effect in the present invention; Described integument wraps up selected probiotic bacteria, Rhizoma amorphophalli powder in it, provides the adapt circumstance space to probiotic bacteria, and during use and play and slow down gastric acid it is damaged, the protection probiotic bacteria enters small intestinal by stomach and survived and revive.
Described oligomeric isomaltose, modern pharmacological research prove to have probiotic bacteria propagation such as the bifidus bacillus of promotion, suppress pathogen and prevent constipation and diarrhoea, and liver function protecting reduces serum cholesterol, is better than the function of eatable cellulose; Described pectin, pharmacological research shows, can increase the viscosity of small intestine contents, directly hinder the solid emulsification of meals gallbladder to the diffusion of intestinal wall mucomembranous cell and bile and cholesterol, disturb the absorption of cholesterol, suppress the heavily absorption of bile acid simultaneously, promote the drainage of bile acid, blocking-up cholesterol enterohepatic circulation finally reduces serum cholesterol level; Described alginate jelly, can make nutrient substance release rate decline in the food by the Degradation of inhibitory enzyme, by increasing the intestinal wall diffusion that intestinal juice concentration hinders nutrient substance, reduce being absorbed chance,, increase enterokinesia by nutrient substance concentration in the effect reduction digestive tract of absorption, parcel, promote that content excretes, the shortening nutrient substance is the time of staying in vivo, and insulin in the blood, serum lipid concentrations are significantly descended, and also has good antiobesity action.
This health-care products of preventing and treating intestinal tract disease of the present invention, and preparation that is provided and using method are compared with medicine with existing method of preventing and treating intestinal tract disease, have following remarkable advantage:
1) two-ways regulation instant effect is observed through on probation, and obstipation or diarrhea patient are taken goods of the present invention according to the present invention prepared goods and using method, produce effects in general 1 week, and patients with mild, 1-2 days can take effect;
2) treating both the principal and secondary aspects of a disease, one product to be used, through many cases existing cathartic and the antibiotics of being better than on probation, take stopgap measures and effect a permanent cure, can not recur, can prevent and treat intestinal tract disease in addition in addition owing to the material life eating patterns change diabetes, hyperlipidemia, hyperglycemia, hypofunction of liver and the cholesterol reducing that causes, fat-reducing waits the health care prophylaxis effect;
3) have no side effect, product sample has no side effect to the people after testing;
4) goods of the present invention and preparation using method can adapt to people's dietary habit, do not change the thing structure of taking food, and not only obtain vast intestinal tract disease patient's welcome, also obtain the high evaluation of health circle.
The specific embodiment:
A kind of health-care products of intestinal tract disease and embodiment 1 of preparation using method thereof of preventing and treating of the present invention: adopt the health-care products of forming by viable bacteria goods and viable bacteria food article of preventing and treating intestinal tract disease, its viable bacteria goods comprise following weight portion raw material: bifidus bacillus 5, lactobacillus 1, Rhizoma amorphophalli powder 4; The viable bacteria food article comprises following weight portion raw material: oligomeric isomaltose 30, Rhizoma amorphophalli powder 10, pectin 10, alginate jelly 10.In the preparation, viable bacteria goods raw material is complied with the manufacture method of conventional capsule preparations by described weight portion, with hard capsule parcel 0.3-0.5 gram/grain, standby, with viable bacteria food article raw material by described weight portion according to conventional electuary (or tablet, pill) manufacture method, it is standby to make electuary (tablet or pill), and above-mentioned capsule-type viable bacteria goods and electuary type viable bacteria food article are pressed 3 and 10 part by weight collocation suit, is prepared into the combination dosage forms goods; During use, take by common cooperation of prompting (description) consumption according to the state of an illness, health.
A kind of health-care products of intestinal tract disease and embodiment 2 of preparation using method of preventing and treating of the present invention: adopt the compound artifact that contains following weight portion raw material prescription, comprise bifidus bacillus 12, lactobacillus 3, the viable bacteria goods of Rhizoma amorphophalli powder 9; Comprise oligomeric isomaltose 60, Rhizoma amorphophalli powder 40, pectin 40, the viable bacteria food article of alginate jelly 40.When preparation and use, 1 and 5 part by weight suit and use pressed in the dosage form preparation of pressing embodiment 1.
A kind of health care compound artifact of intestinal tract disease and embodiment 3 of preparation using method of preventing and treating of the present invention: adopt the compound artifact that contains following weight portion raw material prescription, bifidus bacillus 8, lactobacillus 2, the viable bacteria goods of Rhizoma amorphophalli powder 6; Comprise oligomeric isomaltose 40, Rhizoma amorphophalli powder 20, pectin 20, the viable bacteria food article of alginate jelly 20.When preparation and use, 2 and 8 part by weight suit and use pressed in the dosage form preparation of pressing embodiment 1.
A kind of health care compound artifact and preparation using method of preventing and treating intestinal tract disease of the present invention, through on probation popularization the in nearly thousand patient groups, satisfaction rate almost reaches 100%, does not also receive about invalid feedback of the present invention at present.
Typical case's application example, yellow * *, the man, 60 years old, the intestinal disease was suffered from nearly 10 years by Nanyang City, Henan Province retired employees, main suit, sometimes the constipation couple of days once, stool is as the Semen Juglandis shape, hard pinch not broken; Sometimes diarrhoea, more often not secret not let out stool shapeless, as the congee shape, inevitablely when urinating take some medicated porridge shape stool out of at the anus place at every turn, all will wipe at every turn and just clean for five or six times, often wipe the inflammation of anus portion.More awkward is usually go out to have little time the to look for lavatory so that the underwear of making dirty; Once informal dress antibiotic medicine, stomachic, catharsis medicine, but changeable can not the radical cure.
Treatment: adopt combination dosage forms goods of the present invention and using method August in this year, every day 2 times, each 1 bag, after stool was shaped before this in the 8th day was rare, stool became the Fructus Musae shape in the 9th day, continued to use for 1 week, and tracking is visited, stool is fine always till now, and the mood health also feels relief many than in the past.
Attached Henan Province health and epidemic prevention station examining report two formulas.
Claims (8)
1, a kind of health-care products of preventing and treating intestinal tract disease is characterized in that adopting and is made up of viable bacteria goods and viable bacteria food article.
2, a kind of health-care products of preventing and treating intestinal tract disease as claimed in claim 1 is characterized in that described viable bacteria goods comprise following weight portion raw material: probiotic bacteria 6-15, Rhizoma amorphophalli powder 4-9.
3, a kind of health-care products of preventing and treating intestinal tract disease as claimed in claim 1 is characterized in that described viable bacteria food article comprises following weight portion raw material: oligomeric isomaltose 30-60, pectin 10-40, alginate jelly 10-40, Rhizoma amorphophalli powder 10-40.
4, a kind of health-care products of preventing and treating intestinal tract disease as claimed in claim 1 is characterized in that described viable bacteria goods and viable bacteria food article can also comprise following weight portion raw material respectively: bifidus bacillus 5 in the viable bacteria goods wherein, lactobacillus 1, Rhizoma amorphophalli powder 4; Oligomeric isomaltose 30 in the viable bacteria food article wherein, Rhizoma amorphophalli powder 10, pectin 10, alginate jelly 10.
5, a kind of health-care products of preventing and treating intestinal tract disease as claimed in claim 1 is characterized in that described viable bacteria goods and viable bacteria food article can also comprise following weight portion raw material respectively: bifidus bacillus 12 in the viable bacteria goods wherein, lactobacillus 3, Rhizoma amorphophalli powder 9; Oligomeric isomaltose 60 in the viable bacteria food article wherein, Rhizoma amorphophalli powder 40, pectin 40, alginate jelly 40.
6, a kind of health-care products of preventing and treating intestinal tract disease as claimed in claim 1 is characterized in that described viable bacteria goods and viable bacteria food article can also comprise following weight portion raw material respectively: bifidus bacillus 8 in the viable bacteria goods wherein, lactobacillus 2, Rhizoma amorphophalli powder 6; Oligomeric isomaltose 40 in the viable bacteria food article wherein, Rhizoma amorphophalli powder 20, pectin 20, alginate jelly 20.
7, a kind of preparation using method of preventing and treating the health-care products of intestinal tract disease is characterized in that the viable bacteria goods are placed in the integument, with the viable bacteria food article suit of arranging in pairs or groups in proportion, is prepared into the combination dosage forms goods, and common the cooperation takes by consumption.
8, a kind of preparation using method of preventing and treating the health-care products of intestinal tract disease as claimed in claim 7, it is characterized in that the viable bacteria goods are placed in the capsule, press 1-3 and 5-10 part by weight collocation suit with viable bacteria food article (any dosage form), be prepared into the combination dosage forms goods, take by common cooperation of prompting consumption during use.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100603132A CN100345570C (en) | 2004-12-04 | 2004-12-04 | Health care product for treating intestine duct disease, preparation and use method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100603132A CN100345570C (en) | 2004-12-04 | 2004-12-04 | Health care product for treating intestine duct disease, preparation and use method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1650893A true CN1650893A (en) | 2005-08-10 |
| CN100345570C CN100345570C (en) | 2007-10-31 |
Family
ID=34868778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100603132A Expired - Fee Related CN100345570C (en) | 2004-12-04 | 2004-12-04 | Health care product for treating intestine duct disease, preparation and use method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100345570C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106579414A (en) * | 2016-12-26 | 2017-04-26 | 北京康比特体育科技股份有限公司 | Composition for relieving motility diarrhea |
| CN108294253A (en) * | 2018-01-10 | 2018-07-20 | 温州大学苍南研究院 | With the sargassum fusifome powder and application for adjusting intestinal microflora |
| CN110448569A (en) * | 2019-08-09 | 2019-11-15 | 天道诚数据处理(北京)有限公司 | A kind of composition with antidiarrheal efficacy and preparation method thereof and its application |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1151798C (en) * | 1999-03-10 | 2004-06-02 | 黑龙江省农垦乳品研究所 | Active Bifidobacterium capsule |
| CN1161136C (en) * | 2001-05-29 | 2004-08-11 | 陈永强 | Konjaku capsule for treating type-II diabetes |
-
2004
- 2004-12-04 CN CNB2004100603132A patent/CN100345570C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106579414A (en) * | 2016-12-26 | 2017-04-26 | 北京康比特体育科技股份有限公司 | Composition for relieving motility diarrhea |
| CN108294253A (en) * | 2018-01-10 | 2018-07-20 | 温州大学苍南研究院 | With the sargassum fusifome powder and application for adjusting intestinal microflora |
| CN110448569A (en) * | 2019-08-09 | 2019-11-15 | 天道诚数据处理(北京)有限公司 | A kind of composition with antidiarrheal efficacy and preparation method thereof and its application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100345570C (en) | 2007-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chutkan et al. | Viscous versus nonviscous soluble fiber supplements: mechanisms and evidence for fiber-specific health benefits | |
| Papathanasopoulos et al. | Dietary fiber supplements: effects in obesity and metabolic syndrome and relationship to gastrointestinal functions | |
| Rabbani et al. | Clinical studies in persistent diarrhea: dietary management with green banana or pectin in Bangladeshi children | |
| Singh | Psyllium as therapeutic and drug delivery agent | |
| CN101606704B (en) | Dietary fiber food with various functional actions | |
| CN106666365A (en) | Powder and preparation method thereof | |
| CN1830318A (en) | Dietary fiber food | |
| CN107467462A (en) | A kind of generation meal solid beverage for contributing to fat-reducing and preparation method thereof | |
| CN111227261A (en) | Prebiotic composition and application thereof | |
| CN106579389A (en) | Composition with functions of facilitating feces excretion, losing weight, maintaining beauty and enhancing immunity | |
| CN103156108A (en) | Fortified food for preventing and treating diabetes mellitus and hypertension diseases | |
| CN107198246A (en) | A kind of health composition and a kind of health care preparation | |
| CN111543605A (en) | Comprehensive nutrition powder for people with hypertension, hyperlipidemia and obesity | |
| CN106858621A (en) | A kind of diet fiber composition for adjusting blood pressure and blood lipoid and preparation method thereof | |
| McRorie Jr et al. | Psyllium: The gel-forming nonfermented isolated fiber that delivers multiple fiber-related health benefits | |
| CN1095366C (en) | Application of N-aceto-D-aminoglucose in medicinal preparation for curing intestinal diseases | |
| CN105613882A (en) | Black barley hypoglycemic tea (milky tea) | |
| Tabrizi et al. | Functional laxative foods: Concepts, trends and health benefits | |
| CN100345570C (en) | Health care product for treating intestine duct disease, preparation and use method thereof | |
| CN108523123A (en) | A kind of full nutritional support food of diabetes | |
| CN109965290B (en) | Meal replacement powder for improving intestinal flora and application thereof | |
| Jang et al. | TBG-136, a Schizophyllum commune-derived β-glucan benefits gut microbiota and intestinal health: A randomized, double-blind, and placebo-controlled clinical trial | |
| CN108245531A (en) | It is a kind of to improve gastrointestinal function, the anti-composition to treat constipation | |
| CN113769029A (en) | Medicinal and edible herbal composition for improving intestinal absorption and immune function | |
| CN1676037A (en) | Fruit-vegetable diet cellulose tablet product of nutrient therapeutic food for diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20071031 Termination date: 20131204 |